Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Julianne Qualtieri
Axicabtagene Ciloleucel for CD19+ Plasmablastic Lymphoma
American Journal of Hematology
Hematology
Related publications
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Safety and Efficacy of Axicabtagene Ciloleucel (Axi-Cel) in Older Patients: Results From the Us Lymphoma Car-T Consortium
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Product Characteristics Associated With in Vivo Expansion of Anti-Cd19 Car T Cells in Patients Treated With Axicabtagene Ciloleucel (Axi-Cel)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Preliminary Results of Earlier Steroid Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Large B Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Plasmablastic Lymphoma Mimicking Acute Pancreatitis
Case Reports in Oncological Medicine
Oncology
Safety and Efficacy of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphomas
Therapeutic Advances in Hematology
Hematology
Plasmablastic Lymphoma Versus Diffuse Large B Cell Lymphoma With Plasmablastic Differentiation: Proposal for a Novel Diagnostic Scoring System
Journal of Hematopathology
Forensic Medicine
Pathology
Hematology
Histology
Plasmablastic Lymphoma in the Anal Canal
Cancer Research and Treatment
Cancer Research
Oncology
Primary Plasmablastic Thyroid Lymphoma: A Case Report
AACE Clinical Case Reports